ÂÜÀòÂÒÂ×

Pete Littlewood has extensive experience in the pharmaceutical industry, currently serving as the Director of DMPK at Vertex Pharmaceuticals since January 2011. Prior to this role, Pete held multiple positions as a Team Leader DMPK across several organizations, including Shering Plough, Merck, MSD, Organon Laboratories Ltd, and Merck Frosst Canada from January 2002 to January 2011. Earlier in the career, Pete gained valuable experience as a scientist at Astrazeneca Charnwood from 1999 to 2001. Pete Littlewood holds an education from the University of Leicester.